CoChat

Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening

Open access
Porebski, Benjamin T., Balmforth, Matthew, Browne, Gareth, Riley, Aidan, Jamali, Kiarash, Fürst, Maximillian J. L. J., Velic, Mirko, Buchanan, Andrew, Minter, Ralph, Vaughan, Tristan, Holliger, Philipp · 2023 · Nature Biomedical Engineering
Cited by 72

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Developing therapeutic antibodies is laborious and costly. Here we report a method for antibody discovery that leverages the Illumina HiSeq platform to, within 3 days, screen in the order of 10 8 antibody–antigen interactions. The method, which we named ‘deep screening’, involves the clustering and sequencing of antibody libraries, the conversion of the DNA clusters into complementary RNA clusters covalently linked to the instrument’s flow-cell surface on the same location, the in situ translation of the clusters into antibodies tethered via ribosome display, and their screening via fluorescently labelled antigens. By using deep screening, we discovered low-nanomolar nanobodies to a model antigen using 4 × 10 6 unique variants from yeast-display-enriched libraries, and high-picomolar single-chain antibody fragment leads for human interleukin-7 directly from unselected synthetic repertoires. We also leveraged deep screening of a library of 2.4 × 10 5 sequences of the third complementarity-determining region of the heavy chain of an anti-human epidermal growth factor receptor 2 (HER2) antibody as input for a large language model that generated new single-chain antibody fragment sequences with higher affinity for HER2 than those in the original library.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41551-023-01093-3

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 43

  1. Winter, G. Harnessing evolution to make medicines (Nobel lecture). Angew. Chem. Int. Edit. 58, 14438–14445 (2019). · DOI
  2. Arnold, F. H. Innovation by evolution: bringing new chemistry to life (Nobel lecture). Angew. Chem. Int. Edit. 58, 14420–14426 (2019). · DOI · Paper page
  3. Wilson, D. S. & Szostak, J. W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68, 611–647 (1999). · DOI · Paper page
  4. Rouet, R., Jackson, K. J. L., Langley, D. B. & Christ, D. Next-generation sequencing of antibody display repertoires. Front. Immunol. https://doi.org/10.3389/fimmu.2018.00118 (2018). · DOI
  5. Vodnik, M., Zager, U., Strukelj, B. & Lunder, M. Phage display: selecting straws instead of a needle from a haystack. Molecules 16, 790–817 (2011). · DOI · Paper page
  6. Agresti, J. J. et al. Ultrahigh-throughput screening in drop-based microfluidics for directed evolution. Proc. Natl Acad. Sci. USA 107, 4004–4009 (2010). · DOI · Paper page
  7. Syu, G. D., Dunn, J. & Zhu, H. Developments and applications of functional protein microarrays. Mol. Cell. Proteomics 19, 916–927 (2020). · DOI
  8. Chen, Z. Q., Dodig-Crnkovic, T., Schwenk, J. M. & Tao, S. C. Current applications of antibody microarrays. Clin. Proteomics https://doi.org/10.1186/s12014-018-9184-2 (2018). · DOI
  9. Chen, B. et al. High-throughput analysis and protein engineering using microcapillary arrays. Nat. Chem. Biol. 12, 76–81 (2016). · DOI
  10. Shendure, J. et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309, 1728–1732 (2005). · DOI · Paper page
  11. Buenrostro, J. D. et al. Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes. Nat. Biotechnol. 32, 562–568 (2014). · DOI · Paper page
  12. Tome, J. M. et al. Comprehensive analysis of RNA-protein interactions by high-throughput sequencing-RNA affinity profiling. Nat. Methods 11, 683–688 (2014). · DOI
  13. Svensen, N., Peersen, O. B. & Jaffrey, S. R. Peptide synthesis on a next-generation DNA sequencing platform. ChemBioChem 17, 1628–1635 (2016). · doi:10.1002/cbic.201600298
  14. Layton, C. J., McMahon, P. L. & Greenleaf, W. J. Large-scale, quantitative protein assays on a high-throughput DNA sequencing chip. Mol. Cell 73, 1075–1082.e4 (2019). · DOI
  15. Denny, S. K. & Greenleaf, W. J. Linking RNA sequence, structure, and function on massively parallel high-throughput sequencers. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a032300 (2019). · DOI
  16. Gu, L. C. et al. Multiplex single-molecule interaction profiling of DNA-barcoded proteins. Nature 515, 554–557 (2014). · DOI · Paper page
  17. Cozens, C., Pinheiro, V. B., Vaisman, A., Woodgate, R. & Holliger, P. A short adaptive path from DNA to RNA polymerases. Proc. Natl Acad. Sci. USA 109, 8067–8072 (2012). · DOI
  18. Shimizu, Y. et al. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19, 751–755 (2001). · DOI · Paper page
  19. McMahon, C. et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat. Struct. Mol. Biol. 25, 289–296 (2018). · DOI · Paper page
  20. Lee, L. F. et al. Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc. Natl Acad. Sci. USA 109, 12674–12679 (2012). · DOI · Paper page
  21. Hartgring, S. A. Y. et al. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum. 62, 2716–2725 (2010). · DOI
  22. Kreft, K. L. et al. The IL-7R alpha pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis. J. Immunol. 188, 1874–1883 (2012). · DOI
  23. Coussens, L. et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132–1139 (1985). · DOI · Paper page
  24. Klapper, L. N., Kirschbaum, M. H., Seta, M. & Yarden, Y. Biochemical and clinical implications of the Erbb/HER signaling network of growth factor receptors. Adv. Cancer Res. 77, 25–79 (1999). · DOI · Paper page
  25. Slamon, D. J. et al. Studies of the Her-2/Neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712 (1989). · DOI · Paper page
  26. Lassus, H. et al. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J. Mol. Med. 84, 671–681 (2006). · DOI
  27. Hirsch, F. R. & Langer, C. J. The role of HER2/neu expression and trastuzumab in non-small cell lung cancer. Semin. Oncol. 31, 75–82 (2004). · DOI
  28. Fendly, B. M. et al. Characterization of murine monoclonal-antibodies reactive to either the human epidermal growth-factor receptor or Her2 Neu gene product. Cancer Res. 50, 1550–1558 (1990).
  29. Hudziak, R. M. et al. p185HER2 monoclonal antibody has antiproliferative effects invitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9, 1165–1172 (1989).
  30. McKeage, K. & Perry, C. M. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2. Drugs 62, 209–243 (2002). · DOI · Paper page
  31. Tang, Y. et al. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J. Immunol. 179, 2815–2823 (2007). · DOI · Paper page
  32. Elnaggar, A. et al. ProtTrans: towards cracking the language of life’s code through self-supervised deep learning and high performance computing. Preprint at arXiv https://doi.org/10.48550/arXiv.2007.06225 (2021). · arXiv · doi:10.48550/arxiv.2007.06225 · Paper page
  33. Devlin, J., Chang, M.-W., Lee, K. & Toutanova, K. BERT: pre-training of deep bidirectional transformers for language understanding. In Proc. 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers) 4171–4186 (ACL, 2019).
  34. Glanville, J. et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl Acad. Sci. USA 106, 20216–20221 (2009). · DOI · Paper page
  35. Vollmers, C., Sit, R. V., Weinstein, J. A., Dekker, C. L. & Quake, S. R. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc. Natl Acad. Sci. USA 110, 13463–13468 (2013). · DOI · Paper page
  36. Arnaout, R. et al. High-resolution description of antibody heavy-chain repertoires in humans. PLoS ONE 6, e22365 (2011). · DOI · Paper page
  37. Perelson, A. S. & Oster, G. F. Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self–non-self discrimination. J. Theor. Biol. 81, 645–670 (1979). · DOI · Paper page
  38. Hsu, C., Nisonoff, H., Fannjiang, C. & Listgarten, J. Learning protein fitness models from evolutionary and assay-labeled data. Nat. Biotechnol. 40, 1114–1122 (2022). · DOI · Paper page
  39. Meier, J. et al. Language models enable zero-shot prediction of the effects of mutations on protein function. Preprint at bioRxiv https://doi.org/10.1101/2021.07.09.450648 (2021). · DOI · Paper page
  40. Sohl-Dickstein, J., Weiss, E. A., Maheswaranathan, N. & Ganguli, S. Deep unsupervised learning using nonequilibrium thermodynamics. In Proc. 32nd International Conference on Machine Learning (eds Bach, F. & Blei, D.) 2256–2265 (PMLR, 2015).
  41. Wu, Z. C., Johnston, K. E., Arnold, F. H. & Yang, K. V. K. Protein sequence design with deep generative models. Curr. Opin. Chem. Biol. 65, 18–27 (2021). · DOI · Paper page
  42. Xu, M. et al. GeoDiff: a geometric diffusion model for molecular conformation generation. Preprint at arXiv https://doi.org/10.48550/arXiv.2203.02923 (2022). · arXiv · doi:10.48550/arxiv.2203.02923 · Paper page
  43. Wu, D. et al. Flow-cell-based technology for massively parallel characterization of base-modified DNA aptamers. Anal. Chem. 95, 2645–2652 (2023). · DOI

Cited by

See all 72

Metadata

Authors
Porebski, B. T., Balmforth, M., Browne, G., Riley, A., Jamali, K., Fürst, M. J. L. J., Velic, M., Buchanan, A., Minter, R., Vaughan, T., & Holliger, P.
Venue
Nature Biomedical Engineering
Published
2023-10-09
Volume
8
Issue
3
Pages
214-232
ISSN
2157-846X (ISSN-L)
OpenAlex
W4387451459
Cited by
72
References
24
FWCI
10.63
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • RCUK | Medical Research Council (U105178804)
  • MRC-AstraZeneca Blue Sky Grant BSF24
  • Astra Zeneca
  • European Molecular Biology Organization (ALTF 648-202)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening. https://app.cochat.ai/papers/10.1038/s41551-023-01093-3
The paper
Porebski, B. T., Balmforth, M., Browne, G., Riley, A., Jamali, K., Fürst, M. J. L. J., Velic, M., Buchanan, A., Minter, R., Vaughan, T., & Holliger, P. (2023). Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-023-01093-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.